HPV vaccination intent and willingness to pay for 2-,4-, and 9-valent HPV vaccines: A study of adult women aged 27-45 years in China

首页> 外文期刊>Vaccine >HPV vaccination intent and willingness to pay for 2-,4-, and 9-valent HPV vaccines: A study of adult women aged 27-45 years in China

【24h】

HPV vaccination intent and willingness to pay for 2-,4-, and 9-valent HPV vaccines: A study of adult women aged 27-45 years in China

机译：HPV疫苗接种意图和支付2-，4-和9价HPV疫苗的意愿：对中国27-45岁的成年女性的研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: This study aims to investigate acceptance and willingness to pay for HPV vaccination among adult women in China.

机译：目的：本研究旨在调查中国成人妇女支付HPV疫苗的接受和意愿。

著录项

来源
《Vaccine》 |2020年第14期|共10页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词
HPV vaccination intention; Adult women; China; 2-; 4-and 9-valent HPV vaccines;

机译：HPV疫苗接种意图;成人妇女;中国;2-;4和9价HPV疫苗;

相似文献

外文文献
中文文献

1. HPV vaccination intent and willingness to pay for 2-,4-, and 9-valent HPV vaccines: A study of adult women aged 27-45 years in China [J] . Vaccine . 2020,第14期

机译：HPV疫苗接种意图和支付2-，4-和9价HPV疫苗的意愿：对中国27-45岁的成年女性的研究
2. Factors influencing intention to obtain the HPV vaccine and acceptability of 2-, 4-and 9-valent HPV vaccines: A study of undergraduate female health sciences students in Fujian, China [J] . Lin Yulan, Lin Zheng, He Fei, Vaccine . 2019,第44期

机译：影响意图获得疫苗的意图和2-，4 - 和9价HPV疫苗的可接受性：中国福建省本科女性健康科学研究的研究
3. Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years [J] . EinsteinM.H., BaronM., LevinM.J., Human vaccines . 2011,第12期

机译：人乳头瘤病毒（HPV）-16/18疫苗和HPV-6 / 11/16/18疫苗对18-45岁健康女性非致癌型HPV-31和HPV-45疫苗的免疫原性比较
4. Prevention of human papillomavirus (HPV) infection and HPV-related diseases: Barriers to HPV vaccine coverage among university women in the U.S., and Initial steps in integrating cervical cytology testing into primary care in the Republic of Georgia. [D] . Bednarczyk, Robert A. 2010

机译：预防人乳头瘤病毒（HPV）感染和与HPV相关的疾病：美国大学女性中HPV疫苗覆盖率的障碍，以及在佐治亚州将宫颈细胞学检测纳入初级保健的初始步骤。
5. Efficacy immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III randomised controlled trial [O] . Feng‐Cai Zhu, Shang‐Ying Hu, Ying Hong, 2019

机译：AS04-HPV-16 / 18疫苗在18-25岁的中国女性中的功效免疫原性和安全性：II / III期随机对照试验的研究结束结果
6. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age [O] . Castellsagué, X, Muñoz, N, Pitisuttithum, P, 2011

机译：24-45岁成年女性四价HPV（6、11、16、18型）重组疫苗的研究终点安全性，免疫原性和功效

HPV vaccination intent and willingness to pay for 2-,4-, and 9-valent HPV vaccines: A study of adult women aged 27-45 years in China

摘要

著录项

相似文献

相关主题

期刊订阅